Tirzepatide Reconstitution Guide: How to Mix, Dose & Store

Tirzepatide is a dual-action peptide that has rapidly become one of the most studied compounds in metabolic research. As the first peptide to target both GIP and GLP-1 receptors simultaneously, it represents a genuinely new mechanism — not just an incremental improvement over existing GLP-1 agonists like semaglutide.

If you’re working with lyophilized tirzepatide, this guide covers reconstitution, dosing calculations across the full titration schedule, storage requirements, and practical tips for getting the most out of your vials.

Quick Summary

• Peptide type: Dual GIP/GLP-1 receptor agonist
• Common vial sizes: 5 mg, 10 mg, 15 mg, 30 mg
• Typical research doses: 2.5 mg–15 mg weekly (titrated upward)
• Reconstitute with: Bacteriostatic water
• Storage after reconstitution: 2–8°C (refrigerated) for up to 42 days
• Half-life: ~5 days (supports once-weekly dosing)
• Route: Subcutaneous injection
• Use our Peptide Reconstitution Calculator for instant dosing math

What Is Tirzepatide?

Tirzepatide is a synthetic 39-amino acid peptide that acts on two incretin receptors simultaneously:

• GIP receptor (glucose-dependent insulinotropic polypeptide) — tirzepatide has high affinity for this receptor
• GLP-1 receptor (glucagon-like peptide-1) — tirzepatide has moderate affinity here, roughly 5x less than for GIP

This dual mechanism is what sets tirzepatide apart from semaglutide and other GLP-1-only agonists. The GIP receptor activation adds signaling pathways that influence fat metabolism, adipose tissue function, and appetite regulation through mechanisms that GLP-1 alone doesn’t fully engage.

Like semaglutide, tirzepatide is modified with a C-20 fatty diacid moiety that enables albumin binding, extending its half-life to approximately 5 days — long enough for once-weekly dosing, though slightly shorter than semaglutide’s ~7-day half-life.

How Tirzepatide Differs from Semaglutide

The comparison comes up constantly, so let’s address it directly:

The higher absolute doses of tirzepatide (up to 15 mg vs. 2.4 mg for semaglutide) mean reconstitution math and vial planning are different — you’ll go through vials faster and may need larger vial sizes.

How Tirzepatide Is Supplied

Lyophilized tirzepatide is available in several vial sizes to accommodate the wide dose range:

• 5 mg per vial — suitable for early titration phases
• 10 mg per vial — good for mid-range doses
• 15 mg per vial — matches the maximum single-dose target
• 30 mg per vial — economical for extended protocols at higher doses

The powder is white to off-white and should be stored at -20°C (freezer) for long-term stability or 2–8°C (refrigerator) for shorter-term storage before reconstitution.

How to Reconstitute Tirzepatide

What You’ll Need

• Tirzepatide vial (examples below use multiple sizes)
• Bacteriostatic water (BAC water)
• Insulin syringes for both reconstitution and dosing
• Alcohol swabs

Choosing Your Water Volume

Because tirzepatide doses are relatively large (milligrams, not micrograms), you want a concentration that keeps injection volumes manageable. Here are common setups:

For a 5 mg vial:

For a 10 mg vial:

For a 30 mg vial:

Recommended approach: Use the minimum water volume that keeps your target dose under 100 units (1 mL) per injection. Larger injection volumes are uncomfortable and can affect absorption.

Step-by-Step Reconstitution

1. Remove the flip-off cap from the tirzepatide vial
2. Swab both stoppers (peptide vial and BAC water) with alcohol wipes. Let air dry
3. Draw your chosen volume of BAC water into a syringe
4. Insert the needle through the tirzepatide vial stopper
5. Direct the stream at the glass wall — never spray directly onto the powder
6. Depress slowly over 30–60 seconds. Patience matters here
7. Remove the needle and set the vial down
8. Swirl gently — no shaking. Use slow circular wrist movements
9. Wait 3–5 minutes for complete dissolution. Tirzepatide dissolves well but the larger peptide mass in bigger vials may take slightly longer
10. Check clarity. Solution should be clear and colorless

Need a refresher on reconstitution fundamentals? See our complete mixing guide.

Tirzepatide Dosing: Titration Schedule

Like semaglutide, tirzepatide protocols use a stepwise titration to allow gradual adaptation. The dose increments are larger because tirzepatide is dosed at higher absolute amounts.

Standard Weekly Titration Protocol

Many protocols plateau at 10 mg. The 12.5 mg and 15 mg tiers are used in some research contexts but aren’t always necessary depending on study objectives.

Worked Dosing Example

Scenario: 10 mg vial reconstituted with 1 mL of bacteriostatic water.

Concentration: 10 mg ÷ 1 mL = 10 mg/mL

Total volume: 1 mL = 100 units on an insulin syringe

• 2.5 mg dose: 2.5 ÷ 10 = 0.25 mL = 25 units
• 5 mg dose: 5 ÷ 10 = 0.5 mL = 50 units
• 7.5 mg dose: 7.5 ÷ 10 = 0.75 mL = 75 units
• 10 mg dose: 10 ÷ 10 = 1.0 mL = 100 units (entire vial)

Vial planning at 5 mg/week: A 10 mg vial gives you exactly 2 doses. A 30 mg vial reconstituted with 2 mL gives you 6 doses at 5 mg each. Plan ahead based on where you are in the titration schedule.

For help converting between syringe units and milliliters, see our insulin syringe units guide.

Storage After Reconstitution

Tirzepatide has a slightly shorter reconstituted stability window compared to semaglutide.

Storage Guidelines

• Reconstituted tirzepatide: Refrigerate at 2–8°C
• Stability window: Up to 42 days (6 weeks) after reconstitution
• Never freeze reconstituted solution
• Protect from light — keep in original vial, store away from direct light
• Unreconstituted powder: -20°C for long-term storage

The 42-day window is still generous compared to many peptides. However, if you’re using small vials at higher doses (e.g., a 5 mg vial for a 5 mg dose — one shot per vial), stability is less of a concern since you’ll use the vial immediately.

For comprehensive storage guidance, see our peptide storage guide.

Signs of Degradation

Discard if you see:

• Cloudiness or particulate matter
• Color change (should be colorless)
• Precipitate formation
• Vial left unrefrigerated for extended periods

Injection Guidance

Tirzepatide is given via subcutaneous injection, once weekly.

• Preferred sites: Abdomen, outer thigh, back of upper arm
• Rotate sites weekly to prevent injection-site reactions
• Same day each week for consistent research pharmacokinetics
• Needle gauge: 29–31 gauge insulin syringes

One practical note: at higher doses (10–15 mg), injection volumes can be significant. If you reconstituted a 10 mg vial with 2 mL and need the full 10 mg, that’s a 2 mL injection — uncomfortably large for subcutaneous delivery. This is why reconstituting with less water (1 mL for a 10 mg vial) is preferred at higher doses.

For detailed injection technique, see our subcutaneous injection guide.

Practical Tips for Tirzepatide Research

Match vial size to dose phase. During the 2.5 mg introduction phase, a 5 mg vial lasts 2 weeks. During the 15 mg maintenance phase, you’d need three 5 mg vials per week — a 30 mg vial makes far more sense. Plan ahead.

Label everything. Tirzepatide vials at different concentrations are easy to mix up. Write the reconstitution date, concentration (mg/mL), and discard date (42 days out) on every vial.

Understand the GI adaptation period. The titration schedule exists because GLP-1/GIP agonists can cause significant nausea at high initial doses. Skipping steps or accelerating the schedule often creates problems in research subjects.

Budget for more peptide. At 15 mg/week maintenance, tirzepatide consumption is roughly 6x higher by weight than semaglutide at 2.4 mg/week. Factor this into procurement planning.

Calculate Your Exact Dose

Different vial sizes, water volumes, and titration stages make tirzepatide math more complex than many peptides. Let our calculator do the work.

Try our free Peptide Reconstitution Calculator to calculate your exact tirzepatide dosing.

This content is for educational and research purposes only. Tirzepatide is a research compound. Always follow applicable regulations and consult with qualified professionals regarding research protocols.